TY  - RPRT
TI  - Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs.
AU  - R H Straub
AU  - U Müller-Ladner
AU  - T Lichtinger
AU  - J Schölmerich
AU  - H Menninger
AU  - B Lang
PY  - 1997
DO  - 10.1093/rheumatology/36.12.1298
UR  - https://pubmed.ncbi.nlm.nih.gov/9448591/
ID  - 9448591
ER  -